An ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapy

Head and neck squamous cell carcinoma (HNSCC) is associated with high morbidity and mortality. New personalized treatment strategies represent an unmet medical need to improve the overall survival and the quality of life of patients, which are often limited by the toxicity of established multimodal...

Full description

Saved in:
Bibliographic Details
Main Authors: Almouhanna, Firas (Author) , Heß, Jochen (Author)
Format: Article (Journal)
Language:English
Published: 19 January 2024
In: International journal of molecular sciences
Year: 2024, Volume: 25, Issue: 2, Pages: 1-13
ISSN:1422-0067
DOI:10.3390/ijms25021244
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms25021244
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/2/1244
Get full text
Author Notes:Firas Almouhanna, Jochen Hess

MARC

LEADER 00000caa a2200000 c 4500
001 1902825659
003 DE-627
005 20241205172854.0
007 cr uuu---uuuuu
008 240918s2024 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms25021244  |2 doi 
035 |a (DE-627)1902825659 
035 |a (DE-599)KXP1902825659 
035 |a (OCoLC)1475312169 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Almouhanna, Firas  |d 1994-  |e VerfasserIn  |0 (DE-588)1302302205  |0 (DE-627)1859295096  |4 aut 
245 1 3 |a An ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapy  |c Firas Almouhanna, Jochen Hess 
264 1 |c 19 January 2024 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.09.2024 
520 |a Head and neck squamous cell carcinoma (HNSCC) is associated with high morbidity and mortality. New personalized treatment strategies represent an unmet medical need to improve the overall survival and the quality of life of patients, which are often limited by the toxicity of established multimodal treatment protocols. Several studies have reported an increased expression of the estrogen receptor 1 (ESR1) in HNSCC, but its potential role in the disease outcome of these tumors remains elusive. Using an integrative analysis of multiomics and clinical data from The Cancer Genome Atlas (TCGA)-HNSC, we established a prognostic risk model based on an ESR1-related 25-gene set. The prognostic value was confirmed in an independent cohort of HNSCC and other solid tumors from TCGA. Finally, we performed in silico drug sensitivity modeling to explore potential vulnerabilities for both risk groups. This approach predicted a higher sensitivity for HNSCC, with prominent ESR1 pathway activity under treatment with specific estrogen receptor modulators. In conclusion, our data confirm the involvement of ESR1-related pathway activity in the progression of a defined subset of HNSCC, provide compelling evidence that these tumors share a specific vulnerability to endocrine therapy, and pave the way for preclinical studies and clinical trials to demonstrate the efficacy of this new therapeutic option. 
650 4 |a endocrine therapy 
650 4 |a estrogen receptor alpha 
650 4 |a head and neck cancers 
650 4 |a risk model 
700 1 |a Heß, Jochen  |d 1971-  |e VerfasserIn  |0 (DE-588)121902390  |0 (DE-627)705696057  |0 (DE-576)292983417  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 25(2024), 2, Artikel-ID 1244, Seite 1-13  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a An ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapy 
773 1 8 |g volume:25  |g year:2024  |g number:2  |g elocationid:1244  |g pages:1-13  |g extent:13  |a An ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapy 
856 4 0 |u https://doi.org/10.3390/ijms25021244  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/25/2/1244  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240918 
993 |a Article 
994 |a 2024 
998 |g 121902390  |a Heß, Jochen  |m 121902390:Heß, Jochen  |d 910000  |d 911000  |d 50000  |e 910000PH121902390  |e 911000PH121902390  |e 50000PH121902390  |k 0/910000/  |k 1/910000/911000/  |k 0/50000/  |p 2  |y j 
998 |g 1302302205  |a Almouhanna, Firas  |m 1302302205:Almouhanna, Firas  |p 1  |x j 
999 |a KXP-PPN1902825659  |e 458128872X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","display":"Almouhanna, Firas","given":"Firas","family":"Almouhanna"},{"role":"aut","display":"Heß, Jochen","given":"Jochen","family":"Heß"}],"title":[{"title":"An ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapy","title_sort":"ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapy"}],"id":{"eki":["1902825659"],"doi":["10.3390/ijms25021244"]},"physDesc":[{"extent":"13 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"name":{"displayForm":["Firas Almouhanna, Jochen Hess"]},"recId":"1902825659","relHost":[{"recId":"316340715","note":["Gesehen am 17.09.20"],"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"Molecular Diversity Preservation International","publisherPlace":"Basel"}],"pubHistory":["1.2000 -"],"id":{"eki":["316340715"],"zdb":["2019364-6"],"issn":["1422-0067","1661-6596"]},"language":["eng"],"titleAlt":[{"title":"IJMS"}],"part":{"issue":"2","extent":"13","volume":"25","text":"25(2024), 2, Artikel-ID 1244, Seite 1-13","pages":"1-13","year":"2024"},"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"disp":"An ESR1-related gene signature identifies head and neck squamous cell carcinoma with imputed susceptibility to endocrine therapyInternational journal of molecular sciences","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"19 January 2024"}],"note":["Gesehen am 18.09.2024"]} 
SRT |a ALMOUHANNAESR1RELATE1920